First Time Loading...

Organon & Co
NYSE:OGN

Watchlist Manager
Organon & Co Logo
Organon & Co
NYSE:OGN
Watchlist
Price: 19.61 USD 0.56% Market Closed
Updated: May 4, 2024

Organon & Co
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Organon & Co
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Organon & Co
NYSE:OGN
Cash from Operating Activities
$799m
CAGR 3-Years
-29%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$22.8B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.7B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$13B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$4.2B
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-3%

See Also

What is Organon & Co's Cash from Operating Activities?
Cash from Operating Activities
799m USD

Based on the financial report for Dec 31, 2023, Organon & Co's Cash from Operating Activities amounts to 799m USD.

What is Organon & Co's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-26%

Over the last year, the Cash from Operating Activities growth was -7%. The average annual Cash from Operating Activities growth rates for Organon & Co have been -29% over the past three years , -26% over the past five years .